CVS Health Foundation invests $2.24M to expand community based care through Health Impact Ohio
CVS Health Foundation Invests $2.24 Million to Expand Community‑Based Care Through Health Impact Ohio.
CVS Health Foundation Invests $2.24 Million to Expand Community‑Based Care Through Health Impact Ohio.
The distributor and manufacturer member executives of the HDA Industry Relations Council select the award winners.
Cardinal Health was recognized for a project, “Enhancing DSCSA Transparency Through EDI 852 Quarantine Field Implementation."
The success of Eli Lilly’s Zepbound is encouraging efforts to expand access to obesity treatments by clarifying pricing and reducing costs.
Congressman honored for legislation to lower Americans' drug and healthcare costs and to preserve access to trusted pharmacies
The tribute marks Anderson’s 20 years leading NACDS, highlighting his role in refining strategy, strengthening finances, and boosting influence on healthcare issues.
Now offering customers transparent cash-pay pricing starting at $299 per month for the 2.5 mg KwikPen starter dose and convenient, fast home delivery.
New capabilities will streamline medical prior authorization, benefits investigation and patient enrollment for specialty therapies.
GoodRx Employer Direct enables self-insured employers to subsidize the $449 Lilly Employer Connect medication price for Zepbound KwikPen to reduce employee out-of-pocket costs.
“HDA appreciates the FDA’s work to modernize the NDC system and address long-standing concerns about NDC exhaustion."
Health100, a health technology services subsidiary of CVS Health, will launch a new, first-of-its-kind AI-native consumer engagement platform.
Britt Vitalone announces retirement, Kenny Cheung named as successor.
14-year company veteran will manage expanded sales organization and order intake across multiple business segments.
The changes aim to maintain agile inventory in an increasingly demanding healthcare landscape
Services include vaccines, prescription referrals, and over-the-counter medications.
The report explains pharmaceutical industry tactics and dynamics that increase drug prices for American consumers.